Concepedia

Thomas J. Bunz

TJ

30

Publications

1.1K

Citations

20

H-Index

2008

Active since

Affiliations

University of Connecticut(Current)

Hartford Hospital

Hartford Financial Services (United States)

Bayer (Germany)

SouthCoast Health

Thomas J. Bunz is an author at University of Connecticut specializing in medicine, cardiovascular disease, and thrombosis.

Top concepts

Publications per year

2008–2020

30

Publications

30

Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis

Craig I Coleman, Reinhold Kreutz, Nitesh Sood et al. · The American Journal of Medicine · 2019 · 119 citations

, , +10

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation

Brandon Martinez, Nitesh Sood, Thomas J. Bunz et al. · Journal of the American Heart Association · 2018 · 104 citations · Full text

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack

Craig I Coleman, W. Frank Peacock, Thomas J. Bunz et al. · Stroke · 2017 · 100 citations

Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample

Christine G. Kohn, Mark J. Alberts, W. Frank Peacock et al. · Atherosclerosis · 2019 · 71 citations

, , +11

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

Adrían V. Hernández, G. Bradley, Mohammad Khan et al. · European Heart Journal - Quality of Care and Clinical Outcomes · 2019 · 65 citations

Rows per page

1–5 of 30